Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Core EBITDA Growth

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 14.6689.44-31.9410.9452.63

What is the latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA ?

The latest Core EBITDA Growth ratio of ASTRAZENECA PHARMA INDIA is 14.66 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202414.66
Mar202389.44
Mar2022-31.94
Mar202110.94
Mar202052.63

How is Core EBITDA Growth of ASTRAZENECA PHARMA INDIA Trending?

Years Core EBITDA Growth % Change
Mar2024 14.66
-83.61
Mar2023 89.44
Positive
Mar2022 -31.94
Negative
Mar2021 10.94
-79.21
Mar2020 52.63 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare Core EBITDA Growth ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹17,690.0 Cr -0.5% 6.7% 23.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,143.0 Cr -1.2% 0.9% 41.4% Stock Analytics
DIVIS LABORATORIES ₹154,578.0 Cr -3.7% -1.8% 46.1% Stock Analytics
CIPLA ₹120,185.0 Cr -1.5% 2.2% 16.2% Stock Analytics
DR REDDYS LABORATORIES ₹114,450.0 Cr 1.4% 10.6% 17.2% Stock Analytics
ZYDUS LIFESCIENCES ₹101,569.0 Cr 3.5% 3.6% 37.4% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

-0.5%

6.7%

23.9%

SENSEX

-2.9%

-4.8%

8%


You may also like the below Video Courses